Connetics   Report issue

For profit Phase 2
Founded: Palo Alto CA United States (1993)
Status: Acquired by Stiefel Laboratories (2006) → now GlaxoSmithKline (2009)

Organization Overview

First Clinical Trial
2005
NCT00156247
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Connetics Corp.

Active Ingredients

Drugs in Phase 2 Trials (2)

Key: Connetics (1) Acquired (1)

acitretin (soriatane) (1 trial)

immune globulin (human) (Gamastan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2